Clinical Trial Update: Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose ketamine infusion for pain in children with sickle cell disease; the study is terminated with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Connecticut Children's Medical Center | Conditions: Sickle Cell Disease | Phase 2 | Status: TERMINATED | Results posted: 2016-03-30